3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Melanoma
4
Multiple Myeloma
3
Glioma
3
Thyroid Neoplasms
2
Lymphoma
2
Hematologic Neoplasms
2
Glioblastoma
2
Astrocytoma
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Stomach Neoplasms
1
Refractory Differentiated Thyroid Gland Carcinoma
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Oligodendroglioma
1
Neurofibromatosis 1
1
Neurofibroma, Plexiform
1
Neurocytoma
1
Neuroblastoma
1
Neoplasms
1
Lymphoma, Non-Hodgkin
1
Lung Neoplasms
1
Histiocytosis, Langerhans-Cell
1
Ganglioneuroma
1
Ganglioglioma
1
Esophageal Neoplasms
1
Endometrial Neoplasms
1
Interventions
durvalumab
3
Fulvestrant
3
Cisplatin
3
pembrolizumab
2
abemaciclib
2
Pemetrexed
2
Carboplatin
2
ribociclib
1
repotrectinib
1
palbociclib
1
exemestane
1
enfortumab vedotin
1
elacestrant
1
cemiplimab
1
atezolizumab
1
Tamoxifen
1
STX-478
1
Radiation Dose Hypofractionation
1
RAD1901
1
Oviposition
1
Nivolumab
1
Mitomycin
1
Metformin
1
Letrozole
1
Immunotherapy
1
Imlunestrant
1
Gemcitabine
1
Fluorouracil
1
Drug Therapy
1
Drainage
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neoplasms by Site
×
dabrafenib
×
30 days
×
Clear all
No trials found.